Annotation Detail

Information
Associated Genes
FBXW7
Associated Variants
FBXW7 MUTATION
FBXW7 MUTATION
Associated Disease
cancer
Source Database
CIViC Evidence
Description
418 patients with advanced cancer were screened for FBXW7 mutations using a multiplex gene panel. 17 FBXW7 mutations were detected (isolated mutation in 2 patients). Ten patients were treated with an mTOR inhibitor with 7 patients having stable disease as best responses and a median time to treatment failure of 2.8 months, two patients had prolonged stable disease of >16 weeks.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1631
Gene URL
https://civic.genome.wustl.edu/links/genes/12903
Variant URL
https://civic.genome.wustl.edu/links/variants/281
Rating
2
Evidence Type
Predictive
Disease
Cancer
Evidence Direction
Supports
Drug
MTOR Inhibitor
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
24586741
Drugs
Drug NameSensitivitySupported
MTOR InhibitorSensitivitytrue